CN113546104A - 一种用于慢性心衰的药膳配方及其制作方法 - Google Patents
一种用于慢性心衰的药膳配方及其制作方法 Download PDFInfo
- Publication number
- CN113546104A CN113546104A CN202110965599.2A CN202110965599A CN113546104A CN 113546104 A CN113546104 A CN 113546104A CN 202110965599 A CN202110965599 A CN 202110965599A CN 113546104 A CN113546104 A CN 113546104A
- Authority
- CN
- China
- Prior art keywords
- heart failure
- medicated diet
- chronic heart
- diet formula
- safflower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000005911 diet Nutrition 0.000 title claims abstract description 39
- 230000037213 diet Effects 0.000 title claims abstract description 37
- 206010007558 Cardiac failure chronic Diseases 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 210000002216 heart Anatomy 0.000 claims abstract description 43
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 18
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 13
- 241000132012 Atractylodes Species 0.000 claims abstract description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 235000011477 liquorice Nutrition 0.000 claims abstract description 11
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001061264 Astragalus Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 210000004233 talus Anatomy 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 235000015277 pork Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000007882 dietary composition Nutrition 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 4
- 206010019280 Heart failures Diseases 0.000 abstract description 28
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 238000004393 prognosis Methods 0.000 abstract description 5
- 230000036316 preload Effects 0.000 abstract description 4
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 abstract description 3
- 230000000747 cardiac effect Effects 0.000 abstract description 2
- 230000000378 dietary effect Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 14
- 208000002720 Malnutrition Diseases 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 208000015380 nutritional deficiency disease Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 235000000824 malnutrition Nutrition 0.000 description 9
- 230000001071 malnutrition Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 240000004371 Panax ginseng Species 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 206010006895 Cachexia Diseases 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 235000001188 Peltandra virginica Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 244000061520 Angelica archangelica Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241001660870 Cyrtomium Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 241000736246 Pyrola Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000019269 advanced heart failure Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000011863 diuretic therapy Methods 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000009863 secondary prevention Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009284 tracheal contraction Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于慢性心衰的药膳配方及其制作方法,属于中医中药领域,包括以下重量份的组分:生晒参25‑35g、炒白术5‑15g、茯苓10‑20g、甘草2‑4g、川芎5‑15g、红花4‑8g、生黄芪35‑45g、当归10‑20g;该膳方通过中药的配伍使用,达到降低血液循环中TMAO水平,调节心脏前负荷,改善心力衰竭患者预后,提高生活质量,促进心脏康复的目的。
Description
技术领域
本发明属于中医中药领域,具体涉及一种用于慢性心衰的药膳配方及其制作方法。
背景技术
心力衰竭是由于心肌梗死、心肌病、血流动力学负荷过重、炎症等任何原因引起的心肌损伤,造成心肌结构和功能的变化,最后导致心室泵血或充盈功能低下。临床主要表现为呼吸困难、乏力和体液潴留。慢性心力衰竭(CHF)是指持续存在的心力衰竭状态,可以稳定、恶化或失代偿。治疗心衰的目标不仅要改善症状、提高生活质量,而且要针对心肌重构的机制,延缓和防止心肌重构的发展,降低心衰的住院率和死亡率。
虽然近年来的药物治疗在控制心衰病情方面取得了很大进展,但非药物治疗更能加强对心衰病情的控制,而饮食控制是非药物治疗的基础,作为心血管疾病二级预防的措施之一,是能降低心衰发病率和病死率,且经济、简单、有效、无副作用,影响心衰患者再入院的重要因素之一,但往往是会被忽略的一项。慢性稳定性心衰患者营养不良的发生率为16%~62%,而重度和急性失代偿性心衰患者营养不良的发生率高达75%~90%。研究发现,营养不良的住院心力衰竭患者的预后要比营养状况良好的患者差,营养不良与伤口愈合疾病,术后并发症发生率增加和死亡率之间存在关联。此外,营养不良会使心功能的恶化加重和运动耐力的下降,使心衰患者进入“营养不良-炎性反应-恶病质”的恶性循环。晚期的心力衰竭通常与严重的肌肉消瘦有关,称为心脏恶病质,心脏恶病质是营养不良的预后指标,心衰恶病质的发生率约为15%心脏恶病质会严重降低心力衰竭患者的生存率,一旦患者进入心脏恶病质阶段,即使进行营养支持等各种治疗手段都难以逆转疾,可见慢性心力衰竭(CHF)和营养失调是我们面临的严峻挑战,营养不良经常与慢性心力衰竭并存,营养不良会增加死亡率和住院时间,并导致一系列负面后果。
中医认为,可从小肠入手治疗慢性心力衰竭,小肠主液,紧抓小肠泌别清浊的功能,促进水液代谢,从而减轻心脏循环负荷。中医强调整体观辩证施治,辩证施膳,根据《中药新药临床研究指导原则》心衰分型相关规定,心衰分为心肺气虚型,心肾阳虚型等证型。
中药膳食,所谓“医食同源,药食同根”,根据病人疾病状态、体质差异可辨证施用中药膳食,以调畅气血,平衡阴阳,大量临床试验研究结果显示,中医以小肠入手治疗心衰,心衰辩证分型利水方,如心肺气虚型以益气活血利水方,心肾阳虚以温阳活血利水方等治疗慢性心力衰竭,调节心脏前负荷,对于慢性心衰的中医症状、心功能各项指标、西药的不良反应等有明显的改善,中药与饮食同源,能在日常饮食中补充营养,防治心脏疾病的发生,既不需要刻意迁就于习惯,又能将饮食生活和药疗统一起来,不失为一种有效的疾病防治手段。
发明内容
本发明提供一种用于慢性心衰的药膳配方及其制作方法,该膳方通过中药的配伍使用,达到降低血液循环中TMAO水平,调节心脏前负荷,改善心力衰竭患者预后,提高生活质量,促进心脏康复的目的。
本发明采用的技术方案如下:
一种用于慢性心衰的药膳配方,其特征在于,包括以下重量份的组分:生晒参25-35g、炒白术5-15g、茯苓10-20g、甘草2-4g、川芎5-15g、红花4-8g、生黄芪35-45g、当归10-20g。
优选的方案中,包括以下重量份的组分:生晒参25g、炒白术6g、茯苓12g、甘草2g、川芎8g、红花6g、生黄芪38g、当归14g。
优选的方案中,包括以下重量份的组分:生晒参30g、炒白术10g、茯苓15g、甘草3g、川芎10g、红花6g、生黄芪40g、当归15g。
优选的方案中,包括以下重量份的组分:生晒参35g、炒白术15g、茯苓18g、甘草4g、川芎15g、红花7g、生黄芪45g、当归20g。
优选的方案中,药膳配方还包括50-100g猪心肉。
一种用于慢性心衰的药膳配方的制作方法,包括如下步骤:
1)、获取保鲜周期不超过12小时的新鲜成年猪心50-100g(优选80g/半个猪心);
2)、对选用的新鲜猪心加碱水洗净,切块备用;
3)、将切块备用的新鲜猪心置于锅中加盐,猪心切开口加水煮熟,去渣后捞出;
4)、取权利要求2所述的袋装药膳组合物一袋备用;
5)、将步骤四所取袋装药膳组合物和步骤3处理后的猪心大火煮开,持续10-15分钟(优选15min);转小火煎煮,并不断搅拌,不加盐熬制30~45分钟(优选30min),关火,即得药膳。
本发明所用主要中药原料的药理如下:
生晒参:气清淡,味初淡后稍苦,抑制癌细胞转移,诱导肿瘤细胞凋亡,为极具开发前景的抗癌和抗肿瘤药物。
炒白术:性温,味甘、苦。归脾经、胃经;【功效】燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。
茯苓:茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同;
甘草:又称为国老,甘草味甘,具有清热解毒、润肺止咳、健脾益气、紧急止痛、调和药性的作用,甘草清热解毒,用于治疗脾肺气虚、心气不足。
川芎:别名山鞠穷、芎藭、香果、胡藭、马衔、西芎、贯芎;为伞形科植物川芎Ligusticumchuam.iong Hort.的根茎;【性味归经】性温,味辛。归肝经、胆经、心包经;【药理研究】对心脑血管系统的影响:对心脏有抑制作用;可扩血管,降血压;增加冠脉流量;对心肌及再灌注损伤有保护作用;改善微循环;改善脑循环及脑缺血。改善血液系统、利尿、增强免疫系统;可抑制白三烯、组胺、前列腺素E2引起的气管收缩;能预防和保护肾上腺素所致大鼠实验性肺水肿;有抗肿瘤及抗放射等作用。
红花:【别名】红蓝花、刺红花、草红花;【性味归经】性温,味辛。归心经、肝经;【功效与作用】活血通经、散瘀止痛;【药理研究】具有轻度兴奋心脏、降低冠脉阻力、增加冠脉流量和心肌营养性血流量的作用;抗心肌缺血、心肌梗死、心律失常;改善外周微循环障碍;抗凝血;降血脂;提高耐缺氧能力;兴奋子宫;缓解肠道痉挛;具有免疫活性和抗炎作用;能减轻脑组织中单胺类神经介质的代谢紊乱;可致突变。
生黄芪:亦名戴糁、戴椹、百本、箭芪、百药绵、二人抬;味甘,微温,具有补气固表,托疮生肌、利水的功效;补中益气、止汗、利水消肿、除毒生肌。
当归:别名干归、秦哪、西当归、岷当归、金当归、当归身、涵归尾、文无、当归曲、土当归,多年生草本;性味:甘、辛、温别;【功效与作用】补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
所用君药为生晒参,以补血养阴,填精益髓;炒白术为生地,养阴生津;佐药为茯苓,以健脾和胃,宁心安神,促进身体免疫力;使药为川芎,气香升散,心胸肋痛,气血双调,再辅红花、生黄芪、当归、甘草,清心肺,镇静定心神,止盗汗,再用以脏补脏,药食同源的鲜猪心同煮食肉服汤协同共助,效果甚良;
本发明旨在构建一种简明、完善、系统、易于推广的慢性心衰中医药膳食疗调养营养处方,主要用于心肺气虚型的慢性心力衰竭患者的辅助性治疗,主要功效为益气活血利水,巩固康复治疗,促进心脏康复,改善患者的长期预后,减轻患者负担,提高生活质量,保证心脏正常功能效果显著,可延长发病周期,减少发病次数,减轻发病症状。临床实践证明,可增强抵抗力,提高免疫力,集预防治疗为一体,具有养生、药食同源,无毒无害的现实特点;另外上述散汤剂制备方法简单、可控,适合大规模生产,制备得到的药膳散汤剂充分发挥了“食补”和“药补”二者之长,具有营养丰富和提高机体免疫力,集预防治疗的功效,而且味道可口、适于食用,又能保证营养,患者易于接受的特点,受益于广大心衰患者,值得推广。
附图说明
本发明将通过例子并参照附图的方式说明,其中:
图1是本发明具体实施方式中试验流程示意图;
具体实施方式
为使本申请实施例的目的、技术方案和优点更加清楚,下面将结合本申请实施例中附图,对本申请实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本申请一部分实施例,而不是全部的实施例。通常在此处附图中描述和示出的本申请实施例的组件可以各种不同的配置来布置和设计。因此,以下对在附图中提供的本申请的实施例的详细描述并非旨在限制要求保护的本申请的范围,而是仅仅表示本申请的选定实施例。基于本申请的实施例,本领域技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都属于本申请保护的范围。
在本申请实施例的描述中,需要说明的是,术语“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,或者是该发明产品使用时惯常摆放的方位或位置关系,仅是为了便于描述本申请和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本申请的限制。此外,术语“第一”、“第二”、“第三”等仅用于区分描述,而不能理解为指示或暗示相对重要性。
下面结合图1对本发明作详细说明。
本发明的研究对象:
参照《2020中国心力衰竭诊断和治疗指南》和Framingham关于心衰的定性诊断标准。参照《中药新药临床研究指导原则》心衰分型相关规定,拟选取于2021年06月至2022年11月在成都中医药大学附属医院心血管二科慢性心力衰竭住院患者作为研究对象。
研究对象纳入标准:符合慢性心力衰竭诊断标准;年龄30~75周岁,性别不限;病情许可,依从性好,自愿参与本研究的患者。
排除标准:与慢性心力衰竭诊断标准不符合,或诊断证据不充分;严重失代偿的心力衰竭;急性心肌梗死;活动性心肌炎或心包炎;由于语音理解障碍及不合作等其他原因不能完成答卷者;
实施例1(实验组):
一种用于慢性心衰的药膳配方,包括以下重量份的组分:生晒参25g、炒白术6g、茯苓12g、甘草2g、川芎8g、红花6g、生黄芪38g、当归14g。
所述药膳的制作方法为:获取保鲜周期不超过12小时的新鲜成年猪心50g;对选用的新鲜猪心加碱水洗净,切块备用;将切块备用的新鲜猪心置于锅中加盐,猪心切开口加水煮熟,去渣后捞出;取上述袋装药膳组合物一袋备用;将步骤四所取袋装药膳组合物和步骤3处理后的猪心大火煮开,持续15min;转小火煎煮,并不断搅拌,不加盐熬制30~45分钟,关火,即得药膳。
所述药膳的服用方法为:对于正常患者每天服用三次,每次喝药膳汤50ml;对于水肿患者每天总量控制在50ml。
服用本实施例中所得治疗慢性心衰的药膳,每天早中晚一次,服用1个月后,患者可以病情有明显好转,服用两个疗程后,呼吸困难、乏力等症状基本消失,心衰病情基本得到稳定。
对照例1:(对照组)
患者使用常规饮食护理,满足低盐低脂,易消化饮食,少量多餐,不易过饱的标准。
实验组与对照组出院后3个月的测评效果为:使用本药膳的患者在出院后3个月,心脏前负荷,TMAO水平,呼吸状况水平均比对照组的患者良好,可以得出本药膳可以促进有益营养素摄入量的增加,平衡膳食结构,提高心衰患者临床治疗的效率,改善患者心功能及不良营养代谢状态,提高生活质量,减少再住院率,节省医疗资源,减轻患者负担和痛苦,促进心脏康复的有益效果。
需要说明的是:本发明中的试验的干预方法符合纳入标准的病例均由医生根据病情进行基础治疗。
其中,实验组采用基于“心与小肠相表里”理论指导营养处方护理。具体内容如下:营养处方原则:心衰患者的能量需求取决于目前的干重(无水肿情况下的体重)、活动受限程度以及心衰的程度,一般给予25~30kcal/kg理想体重。每日三餐,科学分配,早餐热量占全天比例约为40%,午餐热量占全天比例为40%,晚餐热量约占全天比例为20%。强调增加日常蔬菜、粗纤维的摄入量,根据水钠潴留和血钠水平,适当限钠,给予不超过3g盐的限钠膳食。若使用利尿剂者,则适当放宽。由于摄入不足、丢失增加或利尿剂治疗等可出现低钾血症,应摄入含钾高的食物。增加低脂乳制品的摄入,减少植物脂肪、动物脂肪的摄入,给予ω-3多不饱和脂肪酸:限制甜食及加工食品的摄入,蛋白质以豆制品、家禽的摄入为主,少食红肉,蛋类摄入需适量,日常烹饪食物时尽可能不食用动物油,尽可能食用植物油,如菜籽油、葵花籽油、橄榄油、茶油等。具体量化指标:每日五谷杂粮400~500g,饱和脂肪摄入量为3~5g,蛋白质摄入量为75~150g,纤维素摄入量为26~30g,钾离子摄入量为4100~4567mg,钙离子摄入量为1040~1200mg,钠盐摄入量为2~5g,确保每日热量摄入量为1600~2000kcal。
以上所述实施例仅表达了本申请的具体实施方式,其描述较为具体和详细,但并不能因此而理解为对本申请保护范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本申请技术方案构思的前提下,还可以做出若干变形和改进,这些都属于本申请的保护范围。
Claims (6)
1.一种用于慢性心衰的药膳配方,其特征在于,包括以下重量份的组分:生晒参25-35g、炒白术5-15g、茯苓10-20g、甘草2-4g、川芎5-15g、红花4-8g、生黄芪35-45g、当归10-20g。
2.根据权利要求1所述的一种用于慢性心衰的药膳配方,其特征在于,包括以下重量份的组分:生晒参25g、炒白术6g、茯苓12g、甘草2g、川芎8g、红花6g、生黄芪38g、当归14g。
3.根据权利要求1所述的一种用于慢性心衰的药膳配方,其特征在于,包括以下重量份的组分生晒参30g、炒白术10g、茯苓15g、甘草3g、川芎10g、红花6g、生黄芪40g、当归15g。
4.根据权利要求1所述的一种用于慢性心衰的药膳配方,其特征在于,包括以下重量份的组分生晒参35g、炒白术15g、茯苓18g、甘草4g、川芎15g、红花7g、生黄芪45g、当归20g。
5.根据权利要求1所述的一种用于慢性心衰的药膳配方,其特征在于,还包括50-100g猪心肉。
6.一种用于慢性心衰的药膳配方的制作方法,其特征在于,包括如下步骤:
1)、获取保鲜周期不超过12小时的新鲜成年猪心50-100g;
2)、对选用的新鲜猪心加碱水洗净,切块备用;
3)、将切块备用的新鲜猪心置于锅中加盐,猪心切开口加水煮熟,去渣后捞出;
4)、取权利要求2所述的袋装药膳组合物一袋备用;
5)、将步骤四所取袋装药膳组合物和步骤3处理后的猪心大火煮开,持续10-15分钟;转小火煎煮,并不断搅拌,不加盐熬制30~45分钟,关火,即得药膳。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110965599.2A CN113546104A (zh) | 2021-08-23 | 2021-08-23 | 一种用于慢性心衰的药膳配方及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110965599.2A CN113546104A (zh) | 2021-08-23 | 2021-08-23 | 一种用于慢性心衰的药膳配方及其制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113546104A true CN113546104A (zh) | 2021-10-26 |
Family
ID=78105889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110965599.2A Pending CN113546104A (zh) | 2021-08-23 | 2021-08-23 | 一种用于慢性心衰的药膳配方及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113546104A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383846A (zh) * | 2001-04-29 | 2002-12-11 | 王运景 | 一种治疗心脏病的强心通脉液 |
CN107126535A (zh) * | 2017-05-17 | 2017-09-05 | 王湧钢 | 植物提取物在中医药领域治病、养生、保健新的应用方法 |
CN109663068A (zh) * | 2018-08-15 | 2019-04-23 | 贵阳中医学院 | 一种用于慢性阻塞性肺疾病急性加重期的药物及其制备方法 |
-
2021
- 2021-08-23 CN CN202110965599.2A patent/CN113546104A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1383846A (zh) * | 2001-04-29 | 2002-12-11 | 王运景 | 一种治疗心脏病的强心通脉液 |
CN107126535A (zh) * | 2017-05-17 | 2017-09-05 | 王湧钢 | 植物提取物在中医药领域治病、养生、保健新的应用方法 |
CN109663068A (zh) * | 2018-08-15 | 2019-04-23 | 贵阳中医学院 | 一种用于慢性阻塞性肺疾病急性加重期的药物及其制备方法 |
Non-Patent Citations (5)
Title |
---|
吴利群,等: "补阳还五汤治疗老年急症举隅", 《中国中医急症》 * |
林楠,等: "中西医结合治疗充血性心衰56例临床观察", 《实用中医内科杂志》 * |
滕国华,等: "心衰的病因病机及其辨证论治", 《中医药学刊》 * |
邢孝民,等: "《实用中医传统康复治疗学 上 第2版》", 31 March 2019, 吉林科学技术出版社 * |
马永俊,等: "温阳益心汤治疗心衰51例", 《光明中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102986887B (zh) | 一种养生风味奶昔及其制备方法 | |
CN104352887A (zh) | 一种具有抗肿瘤综合调养膏方及制备工艺 | |
CN108524814A (zh) | 一种用于降低血糖的中药组合物及其制备方法 | |
CN104489516A (zh) | 提高肿瘤患者术后免疫功能的养生粥及制法 | |
CN105148077A (zh) | 一种具有降血糖功效的养生粥 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN105288340A (zh) | 一种瘦身减肥的中药口服液及制备方法 | |
CN103749819A (zh) | 一种降糖降脂的山茱萸保健茶及其制备方法 | |
CN110522790A (zh) | 一种兼具抗疲劳、提高免疫力和除湿气功效的中药组合物及其制备方法和应用 | |
CN109847047A (zh) | 一种茶的配方及其制备方法 | |
CN106860814B (zh) | 一种改善女性尿频、尿失禁的保健食品组合物及其制备方法和应用 | |
TW202330006A (zh) | 氣虛及/或血虛相關症狀之預防、改善或緩和用之組合物 | |
CN113546104A (zh) | 一种用于慢性心衰的药膳配方及其制作方法 | |
CN103656226A (zh) | 一种治疗干燥综合征复方药 | |
CN112569291A (zh) | 一种用于多囊卵巢综合征的药物组合物及其制备方法 | |
CN104474342A (zh) | 一种适宜三高人群饮用的茶膏及其制备方法 | |
CN104984150A (zh) | 具有降血压功效养生粥的制备工艺 | |
CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
CN110025725A (zh) | 一种治疗心脏病的药物及其制备方法 | |
CN109078157A (zh) | 一种抗肿瘤药物及其制备方法 | |
CN116440221B (zh) | 一种含白芸豆的复方减肥产品及其制备方法和应用 | |
CN109381631A (zh) | 复方固筋骨养肾元粉剂 | |
CN105056160A (zh) | 一种治疗奶牛缺乳症的药物组合物及其制备方法 | |
CN103933149B (zh) | 一种治疗胃病的中药组合物及其制备方法 | |
CN113975238A (zh) | 一种具有健脾促消化功能的补钙钙片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211026 |